期刊文献+

NB-UVB照射联合小剂量阿维A及外用他扎罗汀治疗重度斑块型银屑病疗效观察 被引量:13

Effect of NB-UVB irradiation in combination with a small dose of acitretin and tazarotene 0. 05% gel on severe plaque psoriasis
下载PDF
导出
摘要 入选的重度斑块型银屑病患者146例,采用随机方式,将病例分为治疗组(A组,n=49),给予窄谱中波紫外线(NB-UVB)照射,每周3次,并每晚外用0.05%他扎罗汀凝胶1次;单纯NB-UVB治疗组(B组,n=48),单纯给予NB-UVB照射;单纯他扎罗汀治疗组(C组,n=49),单纯给予0.05%他扎罗汀凝胶外用。3组患者均给予小剂量阿维A口服,4、8周后分别评价疗效,疗程结束12周随访复发情况。结果显示,A、B、C 3组有效率分别为93.9%、72.9%、69.4%,3组间比较差异有统计学意义(P<0.05),未出现较严重的毒副作用,A组复发率也明显低于B组和C组。 146 patients with severe plaque psoriasis were randomly divided into Group A, B and C. In Group A (Treatment Group), 49 patients were given NB-UVB irradiation three times a week and applied tazarotene 0. 05% gel once a night. In Group B ( Control Group 1 ), 48 cases were only given NB-UVB irradiation three times a week. The other patients in Group C ( Control Group 2) were only applied tazarotene 0.05 % gel every night. All the pa- tients were given a small dose [ 0. 3 - 0. 5 mg/( kg ~ d) ] of acitretin. The clinical efficacy was evaluated 4 weeks and 8 weeks after treatment respectively. The follow-up recurrence was assessed 12 weeks after treatment. After 8 weeks' treatment, the effective rates of group A, B and C were 93.9%, 72. 9% and 69.4% respectively. The difference between Group A, Group B and Group A, Group C were both statistically significant ( P 〈 0. 05 ) and relative severe side-effects had not occurred. The recurrence rate in Group A was obviously lower than that of Group B and C.
出处 《安徽医科大学学报》 CAS 北大核心 2013年第7期821-823,共3页 Acta Universitatis Medicinalis Anhui
关键词 斑块型银屑病 窄谱中波紫外线 他扎罗汀 阿维A plaque psoriasis NB-UVB tazarotene acitretin
  • 相关文献

参考文献8

二级参考文献59

  • 1Shun-YuanJiang,Jung-MaoChou,Fur-JiangLeu,Yu-YenHsu,Yu-LungShih,Jyh-CherngYu,Meei-ShyuanLee,Rong-YaunShyu.Decreased expression of type Ⅱ tumor suppressor gene RARRES3 in tissues of hepatocellular carcinoma and cholangiocarcinoma[J].World Journal of Gastroenterology,2005,11(7):948-953. 被引量:2
  • 2王冬云,彭振辉,葛文娱,刘平,王永贤,谭升顺.窄谱UVB联合阿维A治疗斑块型银屑病疗效观察[J].中国皮肤性病学杂志,2005,19(8):477-478. 被引量:14
  • 3陶娟,涂亚庭,熊芬,李延,刘业强,林云,张晓冰.生存素在恶性黑素瘤中的表达及与VEGF和PCNA的关系[J].中华皮肤科杂志,2007,40(3):164-166. 被引量:2
  • 4Schiener R, Behrens-Williams SC, Pillekamp H, et al. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis. Br J Dermatol, 2000, 143(6): 1275-1278.
  • 5Nagpal S, Patel S, Jacobe H, et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol, 1997, 109( 1 ): 91-95.
  • 6Martensson UE, Bristulf J, Owman C, et al. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid. Gene, 2005, 350( 1 ): 65-77.
  • 7Zabel BA, Silverio AM, Butcher EC. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from mycloid dendritic cells in human blood. J Immunol, 2005, 174( 1 ): 244-251.
  • 8Wittamer V, Bondue B, Guillabert A, et al. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J Immunol, 2005, 175( 1 ): 487-493.
  • 9Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med, 2003, 198 (7): 977-985.
  • 10Adams AE, Abu-Amer Y, Chappel J, et al. 1,25 dihydroxyvitamin D3 and dexamethasone induce the cyclooxygenase 1 gene in osteoclast-supporting stromal cells. J Cell Biochem, 1999, 74 (4): 587-595.

共引文献35

同被引文献101

  • 1王冬云,彭振辉,葛文娱,刘平,王永贤,谭升顺.窄谱UVB联合阿维A治疗斑块型银屑病疗效观察[J].中国皮肤性病学杂志,2005,19(8):477-478. 被引量:14
  • 2中华医学会.临床诊疗指南(皮肤病与性病分册)[M].北京:人民卫生出版社,2006,206.
  • 3Eriksson MO,Hagforsen E,Lundin IP,et al.Palmoplantar pustulosis:a clinical and immunohistological study[J].Br J Dermatol,1998,138(3):390-398.
  • 4Uzun G,Karabacak E,Mutluoglu M,et al.Pustulosis palmaris et plantaris[J].BMJ Case Rep,2013,2013,pii:bcr2013009400.
  • 5Huang YC,Chou CL,Chiang YY.Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease:a single-blind,intrapatient left-to-right controlled study[J].Lasers Surg Med,2013,45(2):102-107.
  • 6Pariser DM,Leonardi CL,Gordon K,et al.Integrated safety analysis:short-and long-term safety profiles of etanercept in patients with psoriasis[J].J Am Acad Dermatol,2012,67(2):245-256.
  • 7Van Lümiq PP,Driessen RJ,Kievit W,et al.Results of three analytical approaches on long-term efficacy of etanercept for psoriasis in-daily-practice[J].J Am Acad Dermatol,2013,68(1):57-63.
  • 8Kumar U,Kaur I,Dogra S,et al.Topical tazarotene vs.coal tar in stable plaque psoriasis[J].Clin Exp Dermatol,2010,35(5):482-486.
  • 9Pamela Sears,Yoshi Ichikawa,Nancy Ruiz.Advances in the treatment of Clostridium difficile with fidaxomicin:a narrow spectrum antibiotic[J].Ann.N.Y.Acad.Sci.,2013,12911(7):268-269.
  • 10王忠永,邱会芬,蒋延伟.阿维A对寻常型银屑病患者外周血Th17/Treg细胞转录因子RORγt和Foxp3表达影响的研究[J].中华临床医师杂志(电子版),2012,6(24):8156-8159. 被引量:17

引证文献13

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部